Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cathelicidin antimicrobial peptide (CAMP), specifically its active 37-amino acid C-terminal fragment LL-37, is a vital multifunctional host defense peptide in humans (UniProt P49913). It is primarily expressed by neutrophils and various epithelial cells, where it is stored as the pro-protein hCAP-18 and cleaved upon activation by proteinase 3. LL-37 exhibits potent, broad-spectrum antimicrobial activity by directly disrupting microbial membranes and neutralizing lipopolysaccharides (LPS). Additionally, it functions as a signaling molecule, promoting wound healing, angiogenesis, and the chemotaxis of leukocytes through receptors like Formyl peptide receptor 2 (FPR2). Dysregulation of LL-37 is linked to several pathologies; for instance, its deficiency increases susceptibility to infections in atopic dermatitis, while its overexpression drives auto-inflammatory responses in psoriasis and rosacea. Consequently, LL-37 is a target for therapeutic intervention, with synthetic versions being developed for chronic wound care and inhibitors being explored for autoimmune conditions.
LL-37 functions by directly disrupting microbial cell membranes through pore formation and by binding to host cell receptors, including Formyl peptide receptor 2 (FPR2), P2X7 receptor, and Toll-like receptors, to modulate inflammatory signaling and promote tissue repair.
4 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cathelicidin antimicrobial peptide (LL-37).